Tang Capital's Concentra nabs a win, making a deal to buy Allakos
Tang Capital's shell company Concentra Biosciences secured its first major deal since late 2023. Allakos has agreed to be acquired by Concentra for $0.33 per share in cash, and the California biotech expects the deal ...
Tang Capital's shell company Concentra Biosciences secured its first major deal since late 2023.
Allakos has agreed to be acquired by Concentra for $0.33 per share in cash, and the California biotech expects the deal ...
